PEANA, Massimiliano Francesco
 Distribuzione geografica
Continente #
NA - Nord America 15.282
AS - Asia 7.416
SA - Sud America 4.647
EU - Europa 4.471
Continente sconosciuto - Info sul continente non disponibili 564
AF - Africa 292
OC - Oceania 22
Totale 32.694
Nazione #
US - Stati Uniti d'America 14.940
BR - Brasile 4.126
SG - Singapore 3.226
CN - Cina 1.849
IT - Italia 1.296
UA - Ucraina 1.101
HK - Hong Kong 709
VN - Vietnam 545
DE - Germania 520
FR - Francia 360
SE - Svezia 248
FI - Finlandia 215
GB - Regno Unito 195
AR - Argentina 189
TR - Turchia 151
IN - India 133
CA - Canada 126
RU - Federazione Russa 122
BD - Bangladesh 119
IQ - Iraq 101
EC - Ecuador 96
ZA - Sudafrica 86
MX - Messico 83
UZ - Uzbekistan 73
JP - Giappone 66
VE - Venezuela 60
PK - Pakistan 57
ID - Indonesia 56
CO - Colombia 54
MA - Marocco 54
PL - Polonia 54
NL - Olanda 48
KE - Kenya 39
KR - Corea 39
ES - Italia 38
CZ - Repubblica Ceca 37
RO - Romania 35
JO - Giordania 33
BE - Belgio 30
CL - Cile 28
PE - Perù 28
PH - Filippine 27
TN - Tunisia 27
NP - Nepal 26
PY - Paraguay 26
SA - Arabia Saudita 25
EG - Egitto 24
AE - Emirati Arabi Uniti 22
AU - Australia 22
JM - Giamaica 22
DO - Repubblica Dominicana 20
AZ - Azerbaigian 19
UY - Uruguay 19
CR - Costa Rica 18
DZ - Algeria 18
SI - Slovenia 18
BO - Bolivia 17
EU - Europa 16
RS - Serbia 16
HN - Honduras 15
MY - Malesia 15
OM - Oman 15
AT - Austria 14
IL - Israele 14
KZ - Kazakistan 14
GT - Guatemala 13
AL - Albania 12
HU - Ungheria 12
LT - Lituania 12
SN - Senegal 12
LB - Libano 11
GE - Georgia 10
GR - Grecia 10
IE - Irlanda 10
NO - Norvegia 10
PR - Porto Rico 10
PS - Palestinian Territory 9
TT - Trinidad e Tobago 8
BG - Bulgaria 7
CH - Svizzera 7
DK - Danimarca 7
AM - Armenia 6
GA - Gabon 6
KW - Kuwait 6
PA - Panama 6
SV - El Salvador 6
AO - Angola 5
BY - Bielorussia 5
IR - Iran 5
KG - Kirghizistan 5
LU - Lussemburgo 5
NI - Nicaragua 5
PT - Portogallo 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BN - Brunei Darussalam 4
CY - Cipro 4
EE - Estonia 4
NG - Nigeria 4
Totale 32.089
Città #
Dallas 4.729
Singapore 1.771
San Jose 1.469
Chandler 1.088
Ashburn 943
Hong Kong 702
Jacksonville 626
Council Bluffs 596
Princeton 488
Santa Clara 478
Beijing 402
Columbus 361
New York 311
São Paulo 284
Lauterbourg 247
Nanjing 235
Dearborn 231
Ho Chi Minh City 198
Milan 189
Wilmington 184
Shanghai 180
Hanoi 133
Rio de Janeiro 132
Los Angeles 116
Belo Horizonte 106
Nanchang 93
Boardman 87
Brasília 75
Ann Arbor 73
Shenyang 73
Sassari 70
Tashkent 66
The Dalles 66
Curitiba 62
Porto Alegre 62
Rome 60
Tokyo 58
Helsinki 57
San Francisco 56
Hebei 55
Miano 54
Izmir 53
Chicago 52
Munich 52
Falls Church 51
Tianjin 50
Cagliari 47
Campinas 47
Phoenix 45
Johannesburg 44
Guarulhos 43
Buffalo 42
Changsha 41
Chennai 40
Salvador 39
Baghdad 38
Jiaxing 38
Seoul 37
London 35
Atlanta 34
Hangzhou 34
Woodbridge 34
Brno 33
Nairobi 33
Orem 33
Ribeirão Preto 33
Washington 33
Brooklyn 32
Goiânia 32
Naples 31
Warsaw 31
Brussels 30
Guangzhou 30
Juiz de Fora 30
Dhaka 29
Joinville 29
Quito 29
Toronto 29
Fortaleza 28
Santo André 28
Amman 27
Manaus 27
Osasco 27
São José dos Campos 27
Frankfurt am Main 26
Guayaquil 26
Jakarta 26
Jinan 26
Mexico City 25
Campo Grande 24
Florence 24
Houston 24
Boston 23
Contagem 23
Norwalk 23
Pelotas 23
Denver 22
Falkenstein 22
Montreal 22
Recife 22
Totale 19.204
Nome #
Comparative Analysis of Metal-Binding Properties of C-Terminal FeoB Peptide Models from Selected Gram-Negative Bacteria 1.304
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl 3-({[(5-hydroxy-4-oxo-4H-pyran-2- yl)methoxy]carbonyl}amino)propanoate. Synthesis and its complex formation study 294
A new hydroxypyrone powerful chelator. from synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 248
A potentiometric, spectrophotometric and NMR study of protonation and formation equilibria of four new iron chelators 240
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 236
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 230
Alarming use of chelation therapy 229
Interaction of divalent cations with Park9 protein fragments 215
A Study on Nickel Interaction with Histone H4 Protein 211
An NMR study on the 6,6′-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with AlIII and ZnII ions 210
A family of kojic acid derivatives aimed to remediation of Pb2+ and Cd2+ 205
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 203
Uno Studio di coordinazione tra metalli di interesse biologico e peptidi monoistidinici 201
Coordination abilities of mono and multi-histidinic and glutamate peptide fragments towards manganese(II) and cobalt(II). 198
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 195
An NMR Study on Nickel Binding to Cap43 Protein 192
A Model for Manganese interaction with Deinococcus radiodurans proteome network involved in ROS response and defense 189
An investigation on Ni(ii) ions binding ability with the 429-460 Peptide Fragment from Human Tool like Receptor (htlr4) 188
An NMR study on nickel binding sites in Cap43 protein fragments 179
A Comprehensive Review on Oxysterols and Related Diseases 178
Alarming use of chelation therapy 177
Interaction of Cu(II) and Ni(II) with Ypk9 protein fragment via NMR studies 177
Front cover Dalton Trans., 2013,42, 5945-5945 175
Archaeological Soil Micromorphology Workshop 2015 DIG (Developing International Geoarchaeology) conference DIG2015 173
An updated overview on metal nanoparticles toxicity 170
Ni(II) interaction with a peptide model of the human TLR4 ectodomain 168
The essential metals for humans: A brief overview 166
Ni(ii) binding to the 429-460 peptide fragment from human Toll like receptor (hTLR4): A crucial role for nickel-induced contact allergy? 162
A SARS-CoV-2 –human metalloproteome interaction map 160
Copper(II) binding to Cap43 protein fragments 157
Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography 155
Copper(II) complexes of compartmental ligands: structural and stoichiometric aspects depending upon the anionic group of the copper salt 153
An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes 152
Manganese and Parkinson’s Disease: new findings through a yeast protein study 152
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 151
An NMR study on nickel binding to Cap43 protein 149
Mn(II) and Zn(II) interactions with peptide fragments from Parkinson's disease genes 147
Bidimensional NMR Reveals New Features of Nickel(II) Binding to a Fragment of Cap43 Protein 146
Manganese-peptide complexes involved in radioresistance in Deinococcus radiodurans bacterium 146
Chemical features of in use and in progress chelators for iron overload 145
Exploring the Specificity of Rationally Designed Peptides Reconstituted from the Cell-Free Extract of Deinococcus radiodurans toward Mn(II) and Cu(II) 144
The coordination properties of a small peptide fragment from Human TLR4 sequence are relevant in Nickel Allergy mechanism 142
Environmental barium: potential exposure and health-hazards 142
Nickel(II) binding to Cap43 protein fragments 141
Coordination of Divalent Cations to a Multihistidinic Domain in Cap43 Protein 140
Manganese and cobalt binding in a multi-histidinic fragment 138
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 138
Metal interactions with peptide fragments from Parkinson’s disease genes 138
Silver coordination compounds: A new horizon in medicine 137
Manganese binding to antioxidant peptides involved in extreme radiation resistance in Deinococcus radiodurans 137
Kill or cure: Misuse of chelation therapy for human diseases 135
Nickel binding sites in histone proteins: spectroscopic and structural characterization 135
Investigating the Potential Carcinogenic Effects of Chronic Tungsten (VI) Oxide Exposure to Immortalize Human Lung Cells 134
Nickel binding to histone H4 134
Indagini XRF su ingobbi di ceramiche postmedievali. Modalità di campionamento e possibili interferenze da rivestimenti vetrosi 134
Interaction of divalent cations with protein PARK9 133
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 132
Nickel Binding to Cap43 Protein: an NMR Study 130
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 129
Ni(II) interaction with a histidine-rich region of the human TLR4 protein involved in the activation of nickel contact allergy 129
Malattie neurodegenerative e metalli: cosa lega la sindrome di Parkinson al manganese 128
The binding of Ni(II) and Cu(II) with the N-terminal tail of the histone H4 128
Manganism: the role of YPK9 protein 128
Nickel interaction with mono- and multi-histidinic peptides: understading its toxic and carcinogenic effects 125
Coordination abilities of mono and multi-histidinic and glutamate peptide fragments towards manganese(II) and cobalt(II) 125
NMR characterization of animals’ follicular fluids 125
The Possible Roles of β-alanine and L-carnosine in Anti-aging 124
Hazard and risk associated with the use and development of metal Nanoparticles 124
Experimentally exploring the conformational space sampled by domain reorientation in calmodulin 124
Interaction of protein Cap43 with Ni(II) and Cu(II) ions 124
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 124
Interazione tra l’istone H4 e il nichel: variazioni strutturali 124
Nickel in the Environment and Human Health 123
Tungsten-induced carcinogenesis in human bronchial epithelial cells 123
Molecular Mechanisms of Nickel Carcinogenesis: Nickel Binding to Histone H4 and Cap43 Protein 122
Metal Toxicity and Speciation: A Review 122
The glutathione system in Parkinson's disease and its progression 122
Interaction of Cap43 Protein Fragments with Ni(II) and Cu(II) 122
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions 122
Bidimensional NMR reveals new feature of Nickel(II) binding to a fragment of Cap43 protein 122
Variazioni strutturali indotte dal Ni(II) sul tail dell’istone H4 121
Warns against unapproved 'chelation therapy' 121
The dark side of metal Nps: focus on cancerogenic effects 121
Toxicity of nanoparticles 121
Interaction of Cap43 protein with Ni(II) and Cu(II) ions 120
NMR study of Nickel binding to N-tail of Histone H4 120
Analytical and in silico study of the inclusion complexes between tropane alkaloids atropine and scopolamine with cyclodextrins 120
Spectroscopic characterization of Phoenician-Punic coins 119
Ni(II) binding to 429-460 peptide fragment from human toll-like receptor (hTLR4) 119
Multidimensional NMR spectroscopy for the study of histone H4-Ni(ii) interaction 119
Health benefits of xylitol 119
Zn2+ and Cu2+ Interaction with the Recognition Interface of ACE2 for SARS-CoV-2 Spike Protein 118
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 118
Proteina Cap43 e cationi bivalenti: uno studio sui diversi modi di coordinazione 118
The role of Y-PARK9 protein in Preventing Manganese-induced Parkinson's Disease 117
Ni(II)-Histone H4 Interactions : Structural Modifications 116
NMR characterization of animals’ follicular fluids 116
Cap43 protein interactions with Ni(II) ions: evidences of a possible detoxification role 115
Spectroscopic Aspects of Copper(II) Interaction with a Cap43 Protein Fragment 115
Phosphocalcic metabolism and the role of vitamin D, vitamin K2, and nattokinase supplementation 115
Totale 16.097
Categoria #
all - tutte 132.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022943 0 0 0 31 33 36 43 60 93 56 107 484
2022/20232.221 274 83 51 381 169 407 1 289 371 18 119 58
2023/2024854 119 50 17 16 312 49 34 33 1 20 55 148
2024/20257.944 77 72 429 179 357 318 308 1.610 3.045 988 339 222
2025/202612.394 443 3.850 1.776 1.596 915 461 1.738 312 397 507 287 112
2026/20273.723 328 820 1.123 1.452 0 0 0 0 0 0 0 0
Totale 32.694